ReiThera, the Italian CDMO company specialized in the development and manufacturing of genetic vaccines and advanced therapies, is pleased to announce its participation in the 27th Annual Meeting of ...

Blame Poor EHR Usability for Job Dissatisfaction, 80% Consider Nurse-Friendly Systems When Job Hunting, and 2 in 3 Nurses Under 40 Say EHR Experience Impacts Employer Choice - Black Book's Sweeping ...

Latest preliminary data show continued promising clinical activity in NHL patients, with two complete responses (CR), three partial responses (PR), and three stable disease (SD) as best clinical ...

Neurotrack's screening platform helped to increase the rate of dementia detection by 29% in four months PALM SPRINGS, CA / ACCESS Newswire / May 14, 2025 / In a bold move to improve early detection ...

Data from the cutaneous T-cell lymphoma (CTCL) cohort demonstrate promising clinical activity that correlates with strong immune activationOne complete response (CR), three partial responses (PR), and ...

Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of ...

Blackrock Neurotech to begin immediate sales of Cognixion's Axon-R wearable BCI + augmented reality platform, paving the way for integration of implantable BCI with immersive computing applications ...

Company also expects to provide Q1 performance update pro forma for the pending acquisitions of Sportstech and Wattbike AUSTIN TX / ACCESS Newswire / May 14, 2025 / Interactive Strength Inc.

LUND, SE / ACCESS Newswire / May 14, 2025 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) - The Annual General Meeting (AGM) of Spago Nanomedical AB (publ) was held today, May 14, 2025, at which the AGM ...

EBITDA before special items decreases to 4.085 billion euros (minus 7.4 percent) / Moderate decline in sales (Fx & p adj.) at ...

Johnson & Johnson MedTech, a global leader in breast aesthetics and reconstruction1, today announced the U.S. launch of MENTOR™ MemoryGel™ Enhance Breast Implants, filling a critical gap in ...